PRI — Procalcitonin Assay Class II

FDA Device Classification

FDA product code PRI covers "Procalcitonin Assay", a Class II medical device regulated under 21 CFR 866.3215. Submissions are reviewed by the Microbiology panel. At least 8 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
PRI
Device Class
Class II
Regulation Number
866.3215
Submission Type
510(k)
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

To aid in decision making on antibiotic therapy, including antibiotic initiation and discontinuation, for inpatients or patients in the Emergency Department, with suspected or confirmed lower respiratory tract infections (LRTI) defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K220262Siemens Healthcare DiagnosticsDimension EXL LOCI BRAHMS Procalcitonin (PCT)Aug 26, 2022
K192815Roche DiagnosticsElecsys BRAHMS PCTMar 9, 2020
K173927Roche DiagnosticsElecsys BRAHMS PCTJul 6, 2018
K173683DiasorinLIAISON BRAHMS PCT II GEN, LIAISON Control BRAHMS PCT II GEN, LIAISON BRAHMS PCT…Feb 27, 2018
K172713Fujirebio DiagnosticsLumipulse G B•R•A•H•M•S PCT Immunoreaction Cartridges, Lumipulse G B•R•A•H•M•S…Dec 10, 2017
K170652Fisher DiagnosticsARCHITECT B.R.A.H.M.S PCT, ARCHITECT B.R.A.H.M.S PCT Calibrators, ARCHITECT…Jun 1, 2017
K171338BrahmsB R A H M S PCT sensitive KRYPTORMay 31, 2017
K162827BiomerieuxVIDAS B.R.A.H.M.S. PCT (PCT)Feb 23, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.